In October 2021, over 356,000 people in England had been waiting for over six weeks for a key […]

Fierce Pharma Asia—China’s new NRDL; Biocon-Viatris biosimilar merger?; Avistone’s $200M series A aliu Fri, 12/10/2021 – 02:51

GlaxoSmithKline vet departs for Vifor, the rumored target of a $7.1B CSL buyout fkansteiner Fri, 12/10/2021 – 09:31

Lawmakers blast pharma for ‘outrageous’ prices and ‘anticompetitive conduct’ in culmination of 3-year probe fkansteiner Fri, 12/10/2021 – […]

The UK’s medicines and devices regulator will stop work that “does not add value” and lose over 100 […]

AbstractTwo ideas precede the modern Precautionary Principle. First, that prevention is better than cure, exemplified by an aphorism […]

bmj;375/dec10_6/n3054/FAF1faPhoto credit: Arre BekkeringDutch general practitioner Paul Bekkering recalled the 1970s and confronting a Roman Catholic padre demonstrating […]

A peptide known to prevent the protein error that gives rise to Parkinson’s disease has been optimized by […]

The drug is additionally undergoing assessment with the Medicines and Healthcare products Regulatory Agency for a marketing authorisation […]

In a new report from The Institute of Cancer Research (ICR), data from cancer trials alongside assessments from […]